Clinical utility of targeted next-generation sequencing assay in IDH-wildtype glioblastoma for therapy decision-making.
Lim-Fat MJ, Youssef GC, Touat M, Iorgulescu JB, Whorral S, Allen M, Rahman R, Chukwueke U, McFaline-Figueroa JR, Nayak L, Lee EQ, Batchelor TT, Arnaout O, Peruzzi PP, Chiocca EA, Reardon DA, Meredith D, Santagata S, Beroukhim R, Bi WL, Ligon KL, Wen PY.
Lim-Fat MJ, et al.
Neuro Oncol. 2022 Jul 1;24(7):1140-1149. doi: 10.1093/neuonc/noab282.
Neuro Oncol. 2022.
PMID: 34878541
Free PMC article.